Lysophospholipid enhancement of human T cell sensitivity to diphtheria toxin by increased expression of heparin-binding epidermal growth factor

Proceedings of the Association of American Physicians

Volumn 111, Issue 3, 1999, Pages 259-269

  Goetzl, E J ^a   Kong, Y ^a   Kenney, J S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antisense; G protein coupled receptors; Immunity; Lysophosphatidic acid; Sphingosine 1 phosphate; Thymus

Indexed keywords

DIPHTHERIA TOXIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID; SPHINGOSINE 1 PHOSPHATE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; GENE DELETION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LYMPHOBLASTOMA; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; T LYMPHOCYTE; THYMOCYTE;

EID: 0032969096     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1381.1999.99116.x     Document Type: Article

References (28)

1. 1 Abraham J.A., Damm D., Bajardi A., et al. Heparin‐binding EGF‐like growth factor: Characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. Biochem. Biophys. Res. Commun. 190: 125 133, 1993.
2. 2 Ono M., Raab G., Lau K., et al. Purification and characterization of transmembrane forms of heparin‐binding EGF‐like growth factor. J. Biol. Chem. 269: 31315 31321, 1994.
3. 3 Higashima S., Abraham J.A., Miller J., et al. A heparin‐binding growth factor secreted by macrophage‐like cells that is related to EGF. Science 51: 936 939, 1991.
4. 4 Blotnick S., Peoples G.E., Freeman M.R., et al. T lymphocytes synthesize and export heparin‐binding epidermal growth factor‐like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: Differential production and release by CD4 + and CD8 + T cells. Proc. Natl. Acad. Sci. U.S.A. 91: 2890 2894, 1994.
5. 5 Higashiyama S., Iwamoto R., Goishi K., et al. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane‐anchored heparin‐binding EGF‐like growth factor. J. Cell Biol. 128: 929 938, 1995.
6. 6 Higashiyama S., Abraham J.A., Klagsbrun M. Heparin‐binding EGF‐like growth factor stimulation of smooth muscle cell migration: Dependence on interactions with cell surface heparan sulfate. J. Cell Biol. 122: 933 940, 1993.
7. 7 Naglich J.G., Metherall J.E., Russell D.W., Eidels L. Expression cloning of a diphtheria toxin receptor: Identity with a heparin‐binding EGF‐like growth factor precursor. Cell 69: 1051 1061, 1992.
8. 8 Iwamoto R., Higashiyama S., Mitamura T., et al. Heparin‐binding EGF‐like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP 27/CD9, which up‐regulates functional receptors and diphtheria toxin sensitivity. EMBO J. 13: 2322 2330, 1994.
9. 9 Moolenaar W.H., Kranenburg O., Postma F.R., Zondag C.M. Lysophosphatidic acid: G protein signaling and cellular responses. Curr. Opin. Cell Biol. 9: 168 173, 1997.
10. 10 Spiegel S. & Milstein S. Sphingolipid metabolites: Members of a new class of lipid second messengers. J. Membr. Biol. 146: 225 233, 1995.
11. 11 Brindley D.N., Abousalham A., Kikuchi Y., et al. Cross talk between the bioactive glycerolipids and sphingolipids in signal transduction. Biochem. Cell Biol. 74: 469 476, 1996.
12. 12 Wu J., Spiegel S., Sturgill T.W. Sphingosine 1‐phosphate rapidly activates the mitogen‐activated protein kinase pathway by a G protein‐dependent mechanism. J. Biol. Chem. 270: 11484 11488, 1995.
13. 13 Durieux M.E. & Lynch K.R. Signaling properties of lysophosphatidic acid. Trends Pharmacol. Sci. 14: 249 254, 1993.
14. 14 Goodemote K.A., Mattie M.E., Berger A., Spiegel S. Involvement of a pertussis toxin‐sensitive G protein in the mitogenic signaling pathways of sphingosine 1‐phosphate. J. Biol. Chem. 270: 10272 10277, 1995.
15. 15 Hla T. & Maciag T. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G protein‐coupled receptors. J. Biol. Chem. 265: 9308 9313, 1990.
16. 16 Hecht J.H., Weiner J.A., Post S.R., Chun J. Ventricular zone gene‐1 (vzg‐1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135: 1071 1083, 1996.
17. 17 An S., Dickens M.A., Bleu T., et al. Molecular cloning of the human Edg‐2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. Biochem. Biophys. Res. Comm. 231: 619 622, 1997.
18. 18 An S., Bleu T., Huang W., et al. Identification of cDNAs encoding two G protein‐coupled receptors for lysosphingolipids. FEBS Lett. 417: 279 282, 1997.
19. 19 An S., Bleu T., Hallmark O.G., Goetzl E.J. Characterization of a novel subtype of human G protein‐coupled receptor for lysophosphatidic acid. J. Biol. Chem. 273: 7906 7910, 1998.
20. 20 Goetzl E.J. & An S. A subfamily of G protein‐coupled cellular receptors for lysophospholipids and lysosphingolipids. In: Honn K.V., Nigam S., Marnett L.J., and Dennis E. (eds). Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases. New York: Plenum Press, (in press.)
21. 21 Lee M.‐J., Van Brocklyn J.R., Thangada S., et al. Sphingosine‐1‐phosphate as a ligand for the G protein‐coupled receptor EDG‐1. Science 279: 1552 1555, 1998.
22. 22 Goetzl E.J., An S., Zeng L. Specific suppression by prostaglandin E2 of activation‐induced apoptosis of human CD4 + 8 + T lymphoblasts. J. Immunol. 154: 1041 1047, 1995.
23. 23 Goetzl E.J., Kong Y., Mei B. Lysophosphatidic acid and sphingosine 1‐phosphate protection of T cells from apoptosis in association with suppression of Bax. J. Immunol. 162: 2049 2056, 1999.
24. 24 Guo Z., Liliom K., Fischer D.J., et al. Molecular cloning of a high‐affinity receptor for the growth factor‐like lipid mediator lysophosphatidic acid from Xenopus oocytes. Proc. Natl. Acad. Sci. U.S.A. 93: 14367 14372, 1996.
25. 25 Goetzl E.J. & An S. Diversity of cellular receptors and functions for the lysophospholid growth factors lysophospholid acid and sphingosine 1–phosphate. FASEB J. 12: 1589 1598, 1998.
26. 26 Hill C.S. & Treisman R. Differential activation of c‐fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J. 14: 5037 5047, 1995.
27. 27 Sahai E., Alberts A.S., Treisman R. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. EMBO J. 17: 1350 1361, 1998.
28. 28 Cuvillier O., Rosenthal D.S., Smulson M.E., Spiegel S. Sphingosine 1‐phosphate inhibits activation of caspases that cleave poly (ADP‐ribose) polymerase and lamins during Fas‐ and ceramide‐mediated apoptosis in Jurkat T lymphocytes. J. Biol. Chem. 273: 2910 2916, 1998.